NORDIC BIOSITE ApS: Financial statements 2020
CVR: 30711572
Source: annual report 2020, Danish Business Authority
01/01/2020 – 31/12/2020
NORDIC BIOSITE ApS (CVR 30711572) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK 14,464,025 and a net result of DKK 9,269,458 compared with DKK 1,283,800 the year before. That is an increase of 366.8% compared with the year before. Equity in the 2020 report amounted to DKK 9,686,142. The solvency ratio was 58.2%. The company had 3 employees in the financial year.
- Gross Profit
- DKK 14,464,025
- Profit/Loss
- DKK 9,269,458
- Equity
- DKK 9,686,142
- Total Assets
- DKK 16,642,462
- Employees
- 3
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2020 | - | 14.5 mio. | 9.3 mio. | 9.7 mio. | 3 |
| 2019 | - | 3.1 mio. | 1.3 mio. | 1.4 mio. | 2 |
| 2018 | - | 3 mio. | 945 t. | 1.1 mio. | 3 |
| 2017 | 18 mio. | 2.5 mio. | 880 t. | 1.1 mio. | 2 |
| 2016 | - | 2.3 mio. | 546 t. | 1.2 mio. | 3 |
Official annual report
How creditworthy is NORDIC BIOSITE ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of March 30, 2020, Lars Olof Erhard Gisterå is registered as director of NORDIC BIOSITE ApS.
As of March 30, 2020, Yvonne Diana Zar has stepped down as director of NORDIC BIOSITE ApS.
NORDIC BIOSITE ApS has published its annual report for 2019. Gross profit came to DKK 3,098,374, and the net result was DKK 1,283,800.
As of March 5, 2020, Wilhelmus Catharina Martinus van Hamond has joined the board of directors of NORDIC BIOSITE ApS.
As of March 5, 2020, Lars Olof Erhard Gisterå has joined the board of directors of NORDIC BIOSITE ApS.
As of March 5, 2020, Yvonne Diana Zar has left the board of directors of NORDIC BIOSITE ApS.
As of March 5, 2020, Magnus Åke Lundberg has left the board of directors of NORDIC BIOSITE ApS.
About NORDIC BIOSITE ApS
NORDIC BIOSITE ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2007. The company is registered under the industry Aktiviteter inden for hospitalsvæsen. The management consists of John Philip Bergquist. The board consists of John Philip Bergquist (chair). The company is owned by Nordic Biosite AB. The company has 3 employees (2026). In 2025, the company reported a gross profit of DKK 6,639,125 and a net result of DKK 1,220,258 compared with DKK 1,205,660 the year before. Equity in the 2025 report amounted to DKK 1,808,346.